SCHEMBL28063041

SCHEMBL28063041

CCCCCCC(C)C(=O)ON(CC)CC

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.48
▸ ACE2 Q9BYF1 1/20 0.44
▸ ZDHHC7 Q9NXF8 1/20 0.43
▸ FAAH O00519 1/20 0.41
▸ FFAR1 O14842 2/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.41
▸ GPR84 Q9NQS5 4/20 0.40
▸ FDPS P14324 3/20 0.40
▸ MAPT P10636 2/20 0.39
▸ LCK P06239 1/20 0.39
▸ PPARD Q03181 1/20 0.39
▸ ZDHHC20 Q5W0Z9 1/20 0.39
▸ ZDHHC2 Q9UIJ5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28823108 0.85 L3MBTL1 (0.40) CA1FFAR1FFAR4MAPT
SCHEMBL27915298 0.84 CA1 (0.50) CA1ACE2ZDHHC7FAAHFFAR1
SCHEMBL27321446 0.83 CA1 (0.57) CA1ACE2ZDHHC7FAAHFFAR1
SCHEMBL8052116 0.83 CA1 (0.57) CA1ACE2ZDHHC7FAAHFFAR1
SCHEMBL8994069 0.83 CA1 (0.57) CA1ACE2ZDHHC7FAAHFFAR1
SCHEMBL15754145 0.83 CA1 (0.57) CA1ACE2ZDHHC7FAAHFFAR1
Hydrochloric Acid SCHEMBL27915297 0.82 CA1 (0.48) CA1ACE2ZDHHC7FAAHFFAR1
SCHEMBL27743233 0.81 CA2 (0.53) CA1ZDHHC7FAAHFFAR1GPR84
SCHEMBL27484669 0.81 CA2 (0.53) CA1ZDHHC7FAAHFFAR1GPR84
SCHEMBL1740005 0.81 CA1 (0.59) CA1ACE2ZDHHC7FAAHFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107501264-A The preparation method of diazabicyclooctane derivative 明治制果药业株式会社 2017-12-22 — — CN disclosed
CN-105555787-B Process for preparation of diazabicyclooctane derivatives and intermediates therefor 明治制果药业株式会社 2017-08-08 — — CN disclosed
CN-105555787-A Process for preparation of diazabicyclooctane derivatives and intermediates therefor MEIJI SEIKA PHARMA CO LT 2016-05-04 — — CN disclosed
Send feedback